WNT3, a ligand in the WNT signaling pathway that drives canonical WNT/β-catenin signaling through autocrine or paracrine mechanisms, plays an important role in various biological activities, and has been studied in the context of drug resistance in other cancers. Here, WNT3 is linked to cancer.